TD Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5K | Hold |
60
| – | – | ﹤0.01% | 295 |
|
|
2025
Q1 | $26.1K | Hold |
60
| – | – | ﹤0.01% | 235 |
|
|
2024
Q4 | $22.1K | Hold |
60
| – | – | ﹤0.01% | 236 |
|
|
2024
Q3 | $31K | Buy |
60
+1
| +2% | +$517 | ﹤0.01% | 221 |
|
|
2024
Q2 | $32.2K | Hold |
59
| – | – | ﹤0.01% | 213 |
|
|
2024
Q1 | $30.7K | Hold |
59
| – | – | ﹤0.01% | 214 |
|
|
2023
Q4 | $27.8K | Hold |
59
| – | – | ﹤0.01% | 225 |
|
|
2023
Q3 | $25.6K | Hold |
59
| – | – | ﹤0.01% | 221 |
|
|
2023
Q2 | $26.1K | Buy |
59
+1
| +2% | +$442 | ﹤0.01% | 225 |
|
|
2023
Q1 | $26.9K | Hold |
58
| – | – | ﹤0.01% | 219 |
|
|
2022
Q4 | $29.9K | Hold |
58
| – | – | ﹤0.01% | 195 |
|
|
2022
Q3 | $26K | Buy |
+58
| New | +$26K | ﹤0.01% | 194 |
|
|
2022
Q1 | – | Sell |
-58
| Closed | -$27K | – | 176 |
|
|
2021
Q4 | $27K | Hold |
58
| – | – | ﹤0.01% | 199 |
|
|
2021
Q3 | $21K | Buy |
58
+1
| +2% | +$362 | ﹤0.01% | 200 |
|
|
2021
Q2 | $22K | Hold |
57
| – | – | ﹤0.01% | 195 |
|
|
2021
Q1 | $21K | Buy |
+57
| New | +$21K | ﹤0.01% | 185 |
|